Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China · Delayed Price · Currency is CNY 15.63
-0.09 (-0.57%)
Aug 10, 2026, 3:00 PM CST
SHA:600535 Market Cap
SHA:600535 has a market cap or net worth of 23.48 billion as of August 10, 2026. Its market cap has decreased by -2.48% in one year.
Market Cap
23.48B
Enterprise Value
20.42B
Revenue
8.15B
Ranking
n/a
PE Ratio
19.19
Stock Price
15.63
ChartMarket Cap Chart
Since November 3, 2004, SHA:600535's market cap has increased from 3.65B to 23.48B, an increase of 543.77%. That is a compound annual growth rate of 8.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 23.48B | 4.31% |
| Dec 31, 2025 | 22.51B | 4.22% |
| Dec 31, 2024 | 21.60B | -15.04% |
| Dec 29, 2023 | 25.43B | 59.04% |
| Dec 30, 2022 | 15.99B | -32.76% |
| Dec 31, 2021 | 23.78B | 6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Huahai Pharmaceutical | 26.15B |
| Dizal (Jiangsu) Pharmaceutical | 26.05B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.91B |
| Livzon Pharmaceutical Group | 24.87B |
| Guangdong Zhongsheng Pharmaceutical | 24.29B |
| Hubei Jumpcan Pharmaceutical | 23.87B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.18B |
| Hybio Pharmaceutical | 21.53B |